RETA logo

Reata Pharmaceuticals, Inc. Class A Common Stock

RETA

RETA: Reata Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on identifying, developing, and commercializing therapeutics to address serious and life-threatening diseases by targeting molecular pathways. The company's product in the pipeline include bardoxolone methyl; Omaveloxolone and others.

more

Show RETA Financials

Chart and Financial Data provided by TradingView

All
Government
Consumer Interest
SEC Filings
ESG/Other
Congress Trading

Recent trades of RETA by members of U.S. Congress

Politician Type Traded
Christopher L. Jacobs House / R Sale $1,001 - $15,000 Jan. 04, 2021
Christopher L. Jacobs House / R Purchase $1,001 - $15,000 Dec. 28, 2020
Whale Activity

Recently reported changes by institutional investors

Insider Trading

Quarterly net insider trading by RETA's directors and management

Corporate Lobbying

Government lobbying spending instances

  • $20,000 Jan 22, 2013 Issue: Health Issues
  • $65,000 Oct 19, 2012 Issue: Health Issues
U.S. Patents

New patents grants

  • Patent Title: C4-modified oleanolic acid derivatives for inhibition of il-17 and other uses Feb. 21, 2023
  • Patent Title: Methods of treating alport syndrome using bardoxolone methyl or analogs thereof Sep. 20, 2022
  • Patent Title: C17-heteroaryl derivatives of oleanolic acid and methods of use thereof Aug. 09, 2022
  • Patent Title: Co-crystal forms of a novobiocin analog and proline Aug. 02, 2022
  • Patent Title: Pyrimidine tricyclic enone derivatives for inhibition of ror-gamma and other uses Apr. 05, 2022
  • Patent Title: Pyrazolyl and pyrimidinyl tricyclic enones as antioxidant inflammation modulators Dec. 07, 2021
  • Patent Title: Antioxidant inflammation modulators: oleanolic acid derivatives with amino and other modifications at c-17 Aug. 17, 2021
  • Patent Title: 2,2-difluoropropionamide derivatives of bardoxolone methyl, polymorphic forms and methods of use thereof Aug. 03, 2021
  • Patent Title: Imidazolyl tricyclic enones as antioxidant inflammation modulators Jul. 13, 2021
  • Patent Title: Methods of treating alport syndrome using bardoxolone methyl or analogs thereof Mar. 23, 2021
  • Patent Title: C17-heteroaryl derivatives of oleanolic acid and methods of use thereof Jan. 26, 2021
  • Patent Title: Co-crystal forms of a novobiocin analog and proline Jul. 21, 2020
  • Patent Title: Antioxidant inflammation modulators: oleanolic acid derivatives with amino and other modifications at c-17 Feb. 11, 2020
  • Patent Title: C17-alkanediyl and alkenediyl derivatives of oleanolic acid and methods of use thereof Dec. 10, 2019
  • Patent Title: C17-heteroaryl derivatives of oleanolic acid and methods of use thereof Sep. 03, 2019
  • Patent Title: Methods of treating obesity using antioxidant inflammation modulators Oct. 23, 2018
  • Patent Title: Antioxidant inflamation modulators: oleanolic acid derivatives with amino and other modifications at c-17 Oct. 09, 2018
  • Patent Title: C17-heteroaryl derivatives of oleanolic acid and methods of use thereof Feb. 13, 2018
  • Patent Title: Pyrazolyl and pyrimidinyl tricyclic enones as antioxidant inflammation modulators Feb. 06, 2018
  • Patent Title: Natural product analogs including an anti-inflammatory cyanoenone pharmacore and methods of use Oct. 24, 2017
  • Patent Title: Synthetic triterpenoids and methods of use in the treatment of disease Sep. 12, 2017
  • Patent Title: 2,2-difluoropropionamide derivatives of bardoxolone methyl, polymorphic forms and methods of use thereof Jul. 11, 2017
  • Patent Title: Antioxidant inflammation modulators: oleanolic acid derivatives with amino and other modifications at c-17 Jun. 06, 2017
  • Patent Title: C17-alkanediyl and alkenediyl derivatives of oleanolic acid and methods of use thereof Mar. 14, 2017
  • Patent Title: A-ring epoxidized triterpenoid-based anti-inflammation modulators and methods of use thereof Jan. 31, 2017
  • Patent Title: C17-heteroaryl derivatives of oleanolic acid and methods of use thereof Dec. 06, 2016
  • Patent Title: C4 monomethyl triterpenoid derivatives and methods of use thereof Mar. 22, 2016
  • Patent Title: C13-hydroxy derivatives of oleanolic acid and methods of use thereof Mar. 08, 2016
  • Patent Title: Antioxidant inflammation modulators: c-17 homologated oleanolic acid derivatives Feb. 02, 2016
  • Patent Title: Natural product analogs including an anti-inflammatory cyanoenone pharmacore and methods of use Jan. 12, 2016
  • Patent Title: Pyrazolyl and pyrimidinyl tricyclic enones as antioxidant inflammation modulators Nov. 03, 2015
  • Patent Title: Delayed release, oral dosage compositions that contain amorphous cddo-me Oct. 13, 2015
  • Patent Title: Antioxidant inflammation modulators: oleanolic acid derivatives with amino and other modifications at c-17 Aug. 11, 2015
  • Patent Title: Antioxidant inflammation modulators: oleanolic acid derivatives with saturation in the c-ring Jul. 28, 2015
  • Patent Title: 2,2-difluoropropionamide derivatives of bardoxolone methyl, polymorphic forms and methods of use thereof Mar. 31, 2015
  • Patent Title: Antioxidant inflammation modulators: oleanolic acid derivatives with saturation in the c-ring Jan. 06, 2015
  • Patent Title: Antioxidant inflammation modulators: oleanolic acid derivatives with saturation in the c-ring Dec. 09, 2014
  • Patent Title: Delayed release, oral dosage compositions that contain amorphous cddo-me Jun. 10, 2014
  • Patent Title: Forms of cddo methyl ester Jan. 21, 2014
  • Patent Title: Pyrazolyl and pyrimidinyl tricyclic enones as antioxidant inflammation modulators Aug. 20, 2013
  • Patent Title: Antioxidant inflammation modulators: oleanolic acid derivatives with amino acid and other modifications at c-17 May. 14, 2013
  • Patent Title: Antioxidant inflammation modulators: oleanolic acid derivatives with saturation in the c-ring May. 14, 2013
  • Patent Title: Antioxidant inflammation modulators: c-17 homologated oleanolic acid derivatives Mar. 12, 2013
  • Patent Title: Antioxidant inflammation modulators: novel derivatives of oleanolic acid Dec. 25, 2012
  • Patent Title: Forms of cddo methyl ester Nov. 13, 2012
  • Patent Title: Dehydroandrosterone analogs including an anti-inflammatory pharmacore and methods of use Sep. 04, 2012
  • Patent Title: Synthetic triterpenoids and methods of use in the treatment of disease Mar. 06, 2012
  • Patent Title: Antioxidant inflammation modulators: oleanolic acid derivatives with amino and other modifications at c-17 Feb. 28, 2012
  • Patent Title: Antioxidant inflammation modulators: oleanolic acid derivatives with saturation in the c-ring Feb. 28, 2012
  • Patent Title: Forms of cddo methyl ester Jan. 03, 2012
Government Contracts

Federal grants, loans, and purchases

WallStreetBets

Number of mentions of RETA in WallStreetBets Daily Discussion

RETA News

Recent insights relating to RETA

CNBC Recommendations

Recent picks made for RETA stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in RETA

Corporate Flights

Flights by private jets registered to RETA